These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34773079)

  • 21. Gene therapy: Industrial strength.
    Bender E
    Nature; 2016 Sep; 537(7619):S57-9. PubMed ID: 27602741
    [No Abstract]   [Full Text] [Related]  

  • 22. Mini enzyme moves gene editing closer to the clinic.
    Ledford H
    Nature; 2015 Apr; 520(7545):18. PubMed ID: 25832387
    [No Abstract]   [Full Text] [Related]  

  • 23. New and evolving rare diseases research programs at the National Institutes of Health.
    Groft SC; Rubinstein YR
    Public Health Genomics; 2013; 16(6):259-67. PubMed ID: 24503586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Platform Vector Gene Therapies Project: Increasing the Efficiency of Adeno-Associated Virus Gene Therapy Clinical Trial Startup.
    Brooks PJ; Ottinger EA; Portero D; Lomash RM; Alimardanov A; Terse P; Xu X; Chandler RJ; Geist Hauserman J; Esposito E; Bönnemann CG; Venditti CP; Austin CP; Pariser A; Lo DC
    Hum Gene Ther; 2020 Oct; 31(19-20):1034-1042. PubMed ID: 32993373
    [No Abstract]   [Full Text] [Related]  

  • 25. How to improve the quality of evidence when new treatments are funded conditional on collecting evidence of effectiveness and safety.
    Glynn D; Campbell B; Marlow M; Patrick H
    J Health Serv Res Policy; 2016 Apr; 21(2):71-2. PubMed ID: 26683884
    [No Abstract]   [Full Text] [Related]  

  • 26. [Ophthalmogenetics: Rare Diseases - A Challenge for Diagnostic and Treatment].
    Rudolph G
    Klin Monbl Augenheilkd; 2016 Mar; 232(3):242. PubMed ID: 27011027
    [No Abstract]   [Full Text] [Related]  

  • 27. Fighting rare diseases: the model of the telethon research institutes in Italy.
    Ballabio A; Naldini L
    Hum Gene Ther; 2015 Apr; 26(4):183-5. PubMed ID: 25901396
    [No Abstract]   [Full Text] [Related]  

  • 28. Rare diseases. Foreword.
    Jones LH
    Future Med Chem; 2014 Jun; 6(9):969-70. PubMed ID: 25068979
    [No Abstract]   [Full Text] [Related]  

  • 29. FDA's Foray Into Big Data Still Maturing.
    Kuehn BM
    JAMA; 2016 May; 315(18):1934-6. PubMed ID: 27097048
    [No Abstract]   [Full Text] [Related]  

  • 30. [Rare diseases: "a public health priorty". Interview by Catherine Holué].
    Podeur A
    Rev Prat; 2012 Jan; 62(1):79-80. PubMed ID: 22335073
    [No Abstract]   [Full Text] [Related]  

  • 31. Recent advances in genome editing of stem cells for drug discovery and therapeutic application.
    Lee J; Bayarsaikhan D; Bayarsaikhan G; Kim JS; Schwarzbach E; Lee B
    Pharmacol Ther; 2020 May; 209():107501. PubMed ID: 32061705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Channeling postmarketing patient data into pharmaceutical regulatory systems.
    Barbosa MD; Smith DD
    Drug Discov Today; 2014 Dec; 19(12):1897-912. PubMed ID: 25086288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rare diseases: an "exceptional field of research. Interview by Catherine Holué].
    Dolfus H; Lévy N
    Rev Prat; 2012 Jan; 62(1):89-90. PubMed ID: 22335076
    [No Abstract]   [Full Text] [Related]  

  • 34. Fostering research partnerships: a perspective from The Office of Rare Diseases (ORD).
    Groft SC
    Retina; 2005 Dec; 25(8 Suppl):S86. PubMed ID: 16374356
    [No Abstract]   [Full Text] [Related]  

  • 35. Genetic engineering for haemophilia A.
    Gan SU; Kon OL; Calne RY
    Expert Opin Biol Ther; 2006 Oct; 6(10):1023-30. PubMed ID: 16989584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The consortium project to treat RPE65 deficiency in humans.
    Hauswirth WW
    Retina; 2005 Dec; 25(8 Suppl):S60. PubMed ID: 16374340
    [No Abstract]   [Full Text] [Related]  

  • 37. Beyond basic research for inherited and orphan retinal diseases: successes and challenges.
    Chader GJ
    Retina; 2005 Dec; 25(8 Suppl):S15-S17. PubMed ID: 16374318
    [No Abstract]   [Full Text] [Related]  

  • 38. Engineering targeted viral vectors for gene therapy.
    Waehler R; Russell SJ; Curiel DT
    Nat Rev Genet; 2007 Aug; 8(8):573-87. PubMed ID: 17607305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rare-disease project has global ambitions.
    Abbott A
    Nature; 2011 Apr; 472(7341):17. PubMed ID: 21475168
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of public-private partnerships in addressing the biomedical innovation challenge.
    Said M; Zerhouni E
    Nat Rev Drug Discov; 2014 Nov; 13(11):789-90. PubMed ID: 25359362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.